May
16
Penn Bioethics Seminar (PBS): Alzheimer's Biomarker Disclosure: Where are we? Where are we going?
12:00pm - 1:00pm • Hybrid! 1402 Blockley Hall, 423 Guardian Drive and via Zoom
2023-05-16 12:00:00 2023-05-16 13:00:00 America/New_York Penn Bioethics Seminar (PBS): Alzheimer's Biomarker Disclosure: Where are we? Where are we going? Alzheimer's Biomarker Disclosure: Where are we? Where are we going? Claire Erickson PhD, MPA Postdoctoral Research Fellow, MEHP, PSOM Lunch is provided for in-person attendees. Livestreaming available via Zoom. Alzheimer's disease (AD) is defined by the abnormal accumulation of amyloid and tau proteins in the brain. Clinical trials aimed at modifying Alzheimer's disease processes, namely amyloid accumulation, have been increasingly successful. This talk will describe the current state of research on disclosing AD biomarkers, its increasing relevance given clinical trial results, and will introduce current and developing research projects related to AD biomarker disclosure. Hybrid! 1402 Blockley Hall, 423 Guardian Drive and via Zoom Penn Medical EthicsAlzheimer's Biomarker Disclosure: Where are we? Where are we going?
Claire Erickson PhD, MPA
Postdoctoral Research Fellow, MEHP, PSOM
Lunch is provided for in-person attendees.
Livestreaming available via Zoom.
Alzheimer's disease (AD) is defined by the abnormal accumulation of amyloid and tau proteins in the brain. Clinical trials aimed at modifying Alzheimer's disease processes, namely amyloid accumulation, have been increasingly successful. This talk will describe the current state of research on disclosing AD biomarkers, its increasing relevance given clinical trial results, and will introduce current and developing research projects related to AD biomarker disclosure.